Division of Pediatric Cardiology

September 23, 2019

Tailoring treatment for heart defect

By defining the clinical and genetic factors that predict treatment response, Vanderbilt investigators aim to personalize therapy for a common heart complication in preterm infants.

By Leigh MacMillan
June 10, 2019

Cell-cell signals in developing heart

Scott Baldwin and colleagues have discovered early signaling events during heart development, findings that could guide cell replacement therapies for heart disease.

By Leigh MacMillan
May 29, 2019

Kannankeril elected VP for research of the Pediatric and Congenital Electrophysiology Society

Prince Kannankeril, MD, MSCI, has been elected to serve as vice president for research of the Pediatric and Congenital Electrophysiology Society.

By Christina Echegaray
March 28, 2019

Cardiac dysfunction in DMD

The protein MMP7 is elevated in blood from patients with Duchenne muscular dystrophy who have cardiac dysfunction, suggesting that it may be a biomarker for heart disease severity.

By Leigh MacMillan
August 16, 2018

Risk factors for faulty rhythms

Risk factors for arrhythmias after heart surgery in infants include medications, infant age and higher surgical complexity, but not two genetic variants examined by Vanderbilt researchers.

By Leigh MacMillan
June 26, 2018

Four years ago a Vanderbilt doctor agreed to help run the spelling bee at his daughter’s school. This year she went to the National Spelling Bee.

The trip was a dream come true for Rosy Kannankeril, a rising ninth grader at Franklin Classical School.

By Jessica Pasley
February 9, 2018

Muscular dystrophy clue

Vanderbilt investigators have discovered a role for immune system T cells in slowing the decline in skeletal muscle function in patients with Duchenne muscular dystrophy.
By Meredith Jackson
November 2, 2017

Pediatric cardiologist Johns thrives in many roles

Pediatric cardiologist James Johns, M.D., relishes being a physician who wears many hats.
By Leigh MacMillan
July 3, 2017

NOTCH1 role in heart development

The identification of a genetic culprit for hypoplastic left heart syndrome could lead to new treatments for the condition.
By VUMC News and Communications
April 6, 2017

Initiative seeks to prevent sudden cardiac arrest in children

Monroe Carell Jr. Children’s Hospital at Vanderbilt recently launched a chapter of Project ADAM (Automated Defibrillators in Adam’s Memory), a national organization committed to preventing sudden cardiac arrest in children and teens through education and life-saving programs.
By Jessica Pasley
March 3, 2017

Mutation raises heart block risk

A newly identified genetic risk factor for heart block after surgery may help guide the course of postoperative care.
By Laura Daniel
December 10, 2015

Baldwin awarded AHA’s Helen B. Taussig Memorial Lecture

Scott Baldwin, M.D., director of the Division of Pediatric Cardiology, recently was awarded the American Heart Association’s Helen B. Taussig Memorial Lecture, considered one of the most renowned invited lectures in the United States.
By Christina Echegaray
May 10, 2013

Profiling heart cells

A “profile” of the genes and regulatory networks that govern early heart valve development lay the groundwork for generating valves from a patient’s own cells.
By Leigh MacMillan
1 2 3